Purple Biotech (PPBT) Change in Cash (2017 - 2026)
Purple Biotech (PPBT) reported Change in Cash of -$3.1 million for Q1 2026, down 94.07% year-over-year from -$52.9 million in Q1 2025, and down 259.27% quarter-over-quarter from -$874000.0 in Q4 2025.
Purple Biotech (PPBT) Change in Cash (2017 - 2026) Analysis & Trends
Purple Biotech (PPBT) has 10 years of Change in Cash data on file, last reported at -$3.1 million in Q1 2026.
- Change in Cash for Q1 2026 came in at -$3.1 million, down 94.07% year-over-year; the trailing twelve-month figure through Mar 2026 was -$213000.0 (up 94.93% YoY), and the FY2025 annual result was $1.3 million, up 118.48% from the prior year.
- Change in Cash retreated to -$3.1 million in Q1 2026 per PPBT's latest filing, from -$874000.0 in the prior quarter.
- Over five years, Change in Cash peaked at $6.8 million in Q1 2023 and troughed at -$4.7 million in Q2 2023.
- A 5-year average of -$567400.0 and a median of -$1.1 million in 2024 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2024 and 2025: Change in Cash tumbled 166.18% in 2024, then surged 547.38% in 2025.
- A 5-year view of Change in Cash shows it stood at $3.9 million in 2022, then tumbled by 117.09% to -$662000.0 in 2023, then jumped by 396.53% to $2.0 million in 2024, then tumbled by 144.52% to -$874000.0 in 2025, then sank by 259.27% to -$3.1 million in 2026.
- Business Quant data shows PPBT's Change in Cash at -$3.1 million in Q1 2026, -$874000.0 in Q4 2025, and $4.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -2.44 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -45.97 Mn |
| 10 | Purple Biotech | 242.86 Mn | 236.43 Mn | - | -3.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.14 Mn |
| Dec 31, 2025 | -874,000.00 |
| Sep 30, 2025 | 4.87 Mn |
| Jun 30, 2025 | -1.07 Mn |
| Mar 31, 2025 | -1.62 Mn |
| Dec 31, 2024 | 1.96 Mn |
| Sep 30, 2024 | -1.09 Mn |
| Jun 30, 2024 | -3.46 Mn |
| Mar 31, 2024 | -4.50 Mn |
| Dec 31, 2023 | -662,000.00 |
| Sep 30, 2023 | -2.08 Mn |
| Jun 30, 2023 | -4.66 Mn |
| Mar 31, 2023 | 6.80 Mn |
| Dec 31, 2022 | 3.87 Mn |
| Sep 30, 2022 | -2.88 Mn |
| Dec 31, 2021 | 1.79 Mn |
| Sep 30, 2021 | -1.42 Mn |
| Dec 31, 2020 | -51.82 Mn |
| Dec 31, 2019 | 1.62 Mn |
| Dec 31, 2018 | -74,000.00 |